Your trusted destination for CME, CPD & Medical Education across the Middle East.
Burnbrae
Jim Mellon is a British entrepreneur, investor, author, and philanthropist recognised for his work in investment management, biotechnology, and longevity research. He is the Co-Founder and Deputy Chairman of Juvenescence, a biotechnology company focused on developing therapies targeting ageing and age-related diseases. Through his private investment company, Burnbrae Group, he has investments across several industries, including healthcare, biotechnology, property, banking, and natural resources.
Jim Mellon graduated from the University of Oxford in 1978 with a master's degree in Philosophy, Politics and Economics (PPE). He began his investment career in Asia before moving to the United States, where he worked with fund management companies GT Management and Thornton & Co. In 1991, he established his own investment business, building a portfolio of international investments and business interests.
His growing interest in biotechnology and longevity research led him to explore scientific developments in ageing and the potential commercial applications of advances in regenerative medicine and drug discovery. Together with his partners, he co-founded Juvenescence, which aims to develop medicines targeting biological ageing and age-related conditions. He has also supported scientific research through his involvement with organisations dedicated to extending healthy lifespan.
Beyond biotechnology, Mellon co-founded Agronomics, an investment company focused on cellular agriculture and alternative proteins. He has also held leadership and board positions across financial services, mining, healthcare, and other sectors. His business interests reflect his investment philosophy of identifying emerging industries and technologies with the potential to reshape established markets.

dmg events
dmg events